Hepatitis B
Hepatitis B virus
hepatitis b

Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death

CNO PDF 16 Aug 02
IMPLEMENTATION OF HEPATITIS B IMMUNIZATION FOR NEW ACCESSIONS
ALARACT PDF 04 Oct 94
HEPATITIS B VACCINATION
ALARACT PDF 05 Dec 91
REVISED HEPATITIS B VIRUS (HBV) IMMUNIZATION PROGRAM FOR THE AMEDD AND FOR SOLDIERS POSING IN KOREA
14 Nov 05

Sample Q&A: The Disease

What are the long-term effects of hepatitis B infection?

Each year, about 5,000 people in the U.S. die of hepatitis B-related liver failure. And another 1,500 people die from hepatitis B-related liver cancer.

Hepatitis B infection is the most common cause of liver cancer worldwide and ranks second only to cigarettes as the world's leading cause of cancer.

Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MSMR August 2012: Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,1991-2011
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Defense Health Board (DHB)
Recommendations of the Armed Forces Epidemiological Board (AFEB)
MSMR August 2012: Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,1991-2011
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Comvax (Merck) 01 Dec 10
Package Insert - Vaccine
Hepatitis B Recommendations for Adults
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
VIS
Vaccine Information Statement (Interim)
Vaccine Information Statement
Author(s): Wistrom J, Ahlm C, Lundberg S, Settergren B, Tarnvik A
Publication: Vaccine 17 (1999) 2162-2165
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Hadler S, de Monzon MA, Lugo DR, Perez M
Publication: Vaccine, vol. 7
Subject: Vaccine-Safety
Disease: Hepatitis B
Author(s): Marsano LS, West DJ, Chant I, Hesley TM, Cox J, Hackworth V, Greenberg RN
Publication: Vaccine. Vol. 16. No. 6, pp. 624-629
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Jilg W, Schmidt M, Deinhardt F
Publication: Journal d Medical Virology 17:249-254
Subject: Vaccine-Effectiveness
Disease: Hepatitis B